المؤلفون: Laitman Y; The Oncogenetics Unit, Institute of Human Genetics, and the Meirav High Risk Clinic, Chaim Sheba Medical Center, Tel-Hashomer, Israel., Michaelson-Cohen R; The Medical Genetics Institute and the NOGA High Risk Clinic, Shaare Zedek Medical Center, Affiliated with the Hebrew University School of Medicine, Jerusalem, Israel.; Department of Obstetrics & Gynecology Shaare Zedek Medical Center, Affiliated with the Hebrew University School of Medicine, Jerusalem, Israel., Chen-Shtoyerman R; The Oncogenetics Clinic, The Clinical Genetics Institute, Kaplan Medical Center, Rehovot, Affiliated with the Hebrew University School of Medicine, Jerusalem, Israel., Goldberg Y; Rabin Medical Center, Recanati Genetics Institute, Belinson Hospital, 4941492, Petah Tikvah, Israel., Reish O; Genetics Institute, Shamir Medical Center, Zerifin, Affiliated to The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Bernstein-Molho R; The Oncogenetics Unit, Institute of Human Genetics, and the Meirav High Risk Clinic, Chaim Sheba Medical Center, Tel-Hashomer, Israel.; The Breast Cancer unit, Oncology Institute, Sheba Medical Center, Tel-Hashomer, Israel.; The Department of Human Genetics and Biochemistry, Sackler School of Medicine, Tel-Aviv University, Tel- Aviv, Israel., Levy-Lahad E; The Medical Genetics Institute and the NOGA High Risk Clinic, Shaare Zedek Medical Center, Affiliated with the Hebrew University School of Medicine, Jerusalem, Israel., Baruch NEB; The Oncology Department, Kaplan Medical Center, Rehovot, Affiliated with the Hebrew University School of Medicine, Jerusalem, Israel., Kedar I; Rabin Medical Center, Recanati Genetics Institute, Belinson Hospital, 4941492, Petah Tikvah, Israel., Evans DG; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, United Kingdom.; Division of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Haim S; Genetics Institute, Shamir Medical Center, Zerifin, Affiliated to The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Paluch-Shimon S; Department of Oncology, Shaare Zedek Medical Center, Affiliated with the Hebrew University School of Medicine, Jerusalem, Israel., Friedman E; The Oncogenetics Unit, Institute of Human Genetics, and the Meirav High Risk Clinic, Chaim Sheba Medical Center, Tel-Hashomer, Israel. eitan.friedman@sheba.health.gov.il.; The Department of Human Genetics and Biochemistry, Sackler School of Medicine, Tel-Aviv University, Tel- Aviv, Israel. eitan.friedman@sheba.health.gov.il.

المصدر: Familial cancer [Fam Cancer] 2021 Jul; Vol. 20 (3), pp. 189-194. Date of Electronic Publication: 2020 Nov 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Country of Publication: Netherlands NLM ID: 100898211 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7292 (Electronic) Linking ISSN: 13899600 NLM ISO Abbreviation: Fam Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Age Factors* , Breast Neoplasms*/diagnosis , Breast Neoplasms*/ethnology , Breast Neoplasms*/genetics , Genes, BRCA1* , Germ-Line Mutation* , Heterozygote* , Ovarian Neoplasms*/diagnosis , Ovarian Neoplasms*/ethnology , Ovarian Neoplasms*/genetics, Adult ; England/ethnology ; Female ; Genes, BRCA2 ; Humans ; Iraq/ethnology ; Israel/ethnology ; Jews/genetics ; Middle Aged